The forecast for insulin imports to Italy shows a consistent growth from 2024 to 2028, with values in thousand kilograms increasing from 3.29 in 2024 to 3.72 in 2028. This indicates a steady annual increase, with the year-on-year growth averaging around 3.2%, and a Compound Annual Growth Rate (CAGR) reflecting a smooth upward trend over five years.
Future trends to watch for include potential impacts of domestic production capabilities, changes in diabetes prevalence rates, advancements in insulin technology, and alterations to healthcare policies that could affect import levels. Monitoring these trends will be crucial for understanding future demand dynamics in Italy's insulin market.